date,title,source
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
